Despite remarkable advances in the diagnostic and therapeutic modalities for its
management, cytomegalovirus (CMV) remains one of the most important pathogens …

Immunosuppressive therapy is frequently used to treat gastrointestinal diseases such as
inflammatory bowel disease, autoimmune hepatitis, IgG4-related disease (autoimmune …

Background. Current advances in transplantation practices may influence the development
of cytomegalovirus (CMV) disease after renal transplantation. Methods. From September …

Introduction Patients with primary childhood nephrotic syndrome (PCNS) develop alterations
in their cellular and humoral immunity that predisposes them to the development of infection …

The development of noninvasive biomarkers that reflect the state of immunosuppression (IS)
remains an unmet need in liver transplantation (LT). Torque Teno virus (TTV) is a highly …

An effective host immune response, critical for successful control of Cytomegalovirus (CMV)
disease in solid organ transplant recipients, is affected by intensity and type of …

Immunosuppressive therapy can decrease rejection episodes and increase the risk of
severe and fatal infections in heart transplantation (HT) recipients. Immunosuppressive …

Background Cytomegalovirus (CMV)‐negative recipients of a graft from a CMV‐positive
donor (D+/R−) are at high risk of CMV disease. Current preventive strategies include …

The ongoing COVID‐19 epidemic has brought to the fore many concerns related to use of
immunosuppressive agents (ISAs) in dermatology. While it is unclear whether the patients …

The clinical impact of cytomegalovirus on the outcome of solid organ transplantation
remains evident in the era of antiviral prophylaxis. The challenges of delayed disease and …